Kalirin, RhoGEF Kinase (KALRN) (Middle Region) Peptide
Our Local Distributor
北京 101111
Quick Overview for Kalirin, RhoGEF Kinase (KALRN) (Middle Region) Peptide (ABIN8103609)
抗原
宿主
资源
应用范围
-
-
蛋白结构域
- Middle Region
-
原理
- KALRN Peptide - middle region
-
序列
- GRKSFDLGSP KPGDETTPQG DSADEKSKKG WGEDEPDEES HTPLPPPMKI
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
This is a synthetic peptide designed for use in combination with anti- KALRN Antibody (ARP81502_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
缓冲液
- Lyophilized powder
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- KALRN (Kalirin, RhoGEF Kinase (KALRN))
-
背景
-
Background Information: Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. Alternatively spliced transcript variants encoding different isoforms have been described.
Alternative Symbols: DUO, CHD5, DUET, TRAD, CHDS5, HAPIP, ARHGEF24
-
分子量
- 81 kDa
-
基因ID
- 8997
-
NCBI登录号
- NP_001019831
-
UniProt
- O60229
抗原
-
